Tyrosine Kinase Blockers: New Hope for Successful Cancer Therapy

E-ISSN： 1875-5992|9|1|66-76

ISSN： 1871-5206

Source： Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.9, Iss.1, 2009-01, pp. : 66-76

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tyrosine Kinase Update: Role and Response in Cancer Therapy

Current Cancer Therapy Reviews, Vol. 7, Iss. 2, 2011-05 ,pp. : 155-166

Bentham Science Publishers

Access to resources Recommend Favorite

Systemic therapy of kidney cancer: tyrosine kinase inhibitors, antiangiogenesis or IL-2?

By Kirkali Ziya Tüüzel Emre

Future Oncology, Vol. 5, Iss. 6, 2009-08 ,pp. : 871-888

Future Medicine

Access to resources Recommend Favorite

Regulatory T Cells and Cancer Therapy: An Old Story with a New Hope

Current Cancer Therapy Reviews, Vol. 6, Iss. 1, 2010-02 ,pp. : 34-40

Bentham Science Publishers

Access to resources Recommend Favorite

Is EGF receptor–tyrosine kinase inhibitor therapy in non-small-cell lung cancer patients with EGFR mutations the best option?

By Hayashi Hidetoshi Nakagawa Kazuhiko

Lung Cancer Management, Vol. 2, Iss. 6, 2013-12 ,pp. : 441-443

Future Medicine

Access to resources Recommend Favorite

Editorial [Hot Topic: Tyrosine Kinase Inhibitors in Cancer Therapy (Guest Editor: S. Eckhardt)]

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 8, Iss. 5, 2008-06 ,pp. : 461-461

Bentham Science Publishers

Access to resources Recommend Favorite